Cargando…
Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection
Background: Several studies have indicated that anti-SARS-CoV-2 mRNA vaccinations are less effective in inducing robust immune responses among solid organ transplant recipients (SOTRs) compared with the immunocompetent. The third dose of vaccine in SOTRs showed promising results of immunogenicity, e...
Autores principales: | Miele, Monica, Busà, Rosalia, Russelli, Giovanna, Sorrentino, Maria Concetta, Di Bella, Mariangela, Timoneri, Francesca, Vitale, Giampiero, Calzolari, Elisa, Vitulo, Patrizio, Mularoni, Alessandra, Conaldi, Pier Giulio, Bulati, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415050/ https://www.ncbi.nlm.nih.gov/pubmed/36013981 http://dx.doi.org/10.3390/microorganisms10081563 |
Ejemplares similares
-
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant Recipients
por: Busà, Rosalia, et al.
Publicado: (2022) -
Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
por: Miele, Monica, et al.
Publicado: (2021) -
Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells
por: Busà, Rosalia, et al.
Publicado: (2022) -
Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components
por: Busà, Rosalia, et al.
Publicado: (2022) -
Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment
por: Chinnici, Cinzia Maria, et al.
Publicado: (2021)